These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38153518)

  • 61. [Prediction of treatment outcome after adjuvant loco-regional chemotherapy following liver resection for colorectal metastases--preliminary results].
    Strnad R; Ryska M; Belina F; Langer D; Novotný J; Ludvíková M
    Rozhl Chir; 2006 Mar; 85(3):124-8. PubMed ID: 16689143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.
    Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Ariyoshi K; Oyamada S; Iwase S
    BMJ Open; 2018 Jul; 8(7):e021442. PubMed ID: 30030317
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
    Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
    J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients.
    Lund JL; Stürmer T; Sanoff HK; Brookhart A; Sandler RS; Warren JL
    Cancer; 2013 Jun; 119(11):2038-47. PubMed ID: 23512326
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
    Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
    Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
    Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
    Antonio M; Saldaña J; Carmona-Bayonas A; Navarro V; Tebé C; Nadal M; Formiga F; Salazar R; Borràs JM
    Oncologist; 2017 Aug; 22(8):934-943. PubMed ID: 28487465
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
    Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recurrence and cancer-specific death after adjuvant chemotherapy for Stage III colon cancer.
    Chapuis PH; Bokey E; Chan C; Keshava A; Rickard MJFX; Stewart P; Young CJ; Dent OF
    Colorectal Dis; 2019 Feb; 21(2):164-173. PubMed ID: 30253025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Principles of oncologic drug therapy following surgery for bowel cancer].
    Ristamäki R; Ålgars A
    Duodecim; 2016; 132(12):1155-9. PubMed ID: 27483631
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer.
    Hoshino N; Kawada K; Hida K; Goto S; Uozumi R; Hasegawa S; Sugihara K; Sakai Y
    Med Oncol; 2017 Aug; 34(8):138. PubMed ID: 28699092
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The aetiology of delay to commencement of adjuvant chemotherapy following colorectal resection.
    Simpson GS; Smith R; Sutton P; Shekouh A; McFaul C; Johnson M; Vimalachandran D
    Int J Surg Oncol; 2014; 2014():670212. PubMed ID: 24757562
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Time to adjuvant chemotherapy following colorectal cancer resection is associated with an improved survival.
    Day AR; Middleton G; Smith RV; Jourdan IC; Rockall TA
    Colorectal Dis; 2014 May; 16(5):368-72. PubMed ID: 24456198
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases.
    Virzì S; Iusco D; Baratti D; Bonomi S; Grassi A; Kusamura S; Deraco M
    Tumori; 2013; 99(5):589-95. PubMed ID: 24362862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term survival benefits of adjuvant chemotherapy by decreasing incidence of tumor recurrence without delaying relapse in stage III colorectal cancer.
    Tsai WS; Hsieh PS; Yeh CY; Chiang JM; Tang R; Chen JS; Changchien CR; Wang JY
    Int J Colorectal Dis; 2011 Oct; 26(10):1329-38. PubMed ID: 21556841
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer.
    Ito K; Yamaguchi A; Miura K; Kato T; Koike A; Takagi H
    J Surg Oncol; 1996 May; 62(1):4-9. PubMed ID: 8618399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
    Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential clinical benefits of 5-fluorouracil-based adjuvant chemotherapy for patients with stage III colorectal cancer according to CD133 expression status.
    Shikina A; Shinto E; Hashiguchi Y; Ueno H; Naito Y; Okamoto K; Kubo T; Fukazawa S; Yamamoto J; Hase K
    Jpn J Clin Oncol; 2014 Jan; 44(1):42-8. PubMed ID: 24244031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.